Emprumapimod
Emprumapimod (PF-07265803) is an orally active and specific inhibitor of mitogen-activated protein kinase p38α MAPK, inhibits LPS-induced production of IL-6, and can be used to study dilated cardiomyopathy induced by the LMNA gene.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
473.52
Molecular Formula
C24H29F2N5O3
Notes
Research use only, not for human use.
Receptor
P38 MAPK
CAS Number
765914-60-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1082727-01 0.02 mg (E-Coli)
Recombinant Salinispora arenicola Glutamate 5-kinase (proB)
Ask
View Details MBS1082727-02 0.02 mg (Yeast)
Recombinant Salinispora arenicola Glutamate 5-kinase (proB)
Ask
View Details 
MBS1082727-03 0.1 mg (E-Coli)
Recombinant Salinispora arenicola Glutamate 5-kinase (proB)
Ask
View Details MBS1082727-04 0.1 mg (Yeast)
Recombinant Salinispora arenicola Glutamate 5-kinase (proB)
Ask
View Details MBS1082727-05 0.02 mg (Baculovirus)
Recombinant Salinispora arenicola Glutamate 5-kinase (proB)
Ask
View Details MBS1082727-06 0.02 mg (Mammalian-Cell)
Recombinant Salinispora arenicola Glutamate 5-kinase (proB)
Ask
View Details